Mcdonald Partners LLC Sells 84 Shares of The Clorox Company (NYSE:CLX)

Mcdonald Partners LLC cut its stake in The Clorox Company (NYSE:CLX) by 2.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,888 shares of the company’s stock after selling 84 shares during the period. Mcdonald Partners LLC’s holdings in Clorox were worth $632,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Brooklyn Investment Group lifted its holdings in Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after buying an additional 95 shares during the period. Prospera Private Wealth LLC purchased a new stake in Clorox in the third quarter worth about $27,000. Continuum Advisory LLC lifted its holdings in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after buying an additional 138 shares during the period. Asset Planning Inc purchased a new stake in Clorox in the fourth quarter worth about $32,000. Finally, Carolina Wealth Advisors LLC purchased a new stake in Clorox in the third quarter worth about $48,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CLX has been the subject of several research analyst reports. JPMorgan Chase & Co. raised their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and lifted their target price for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Barclays lifted their target price on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a report on Wednesday, February 5th. Wells Fargo & Company lifted their target price on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Finally, StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $158.21.

Clorox Trading Down 1.9 %

Shares of Clorox stock opened at $147.91 on Tuesday. The company has a market capitalization of $18.31 billion, a P/E ratio of 40.41, a P/E/G ratio of 2.52 and a beta of 0.42. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.62 and a current ratio of 0.94. The company has a fifty day moving average of $158.78 and a 200 day moving average of $159.71. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37.

Clorox (NYSE:CLX) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the company posted $2.16 earnings per share. On average, sell-side analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.